UCB and N-SIDE increase their strategic collaboration
Louvain-la-Neuve, Belgium, 2nd June 2020 / Sciad Newswire / N-SIDE, provider of innovative software and strategic consulting services, announced that UCB has signed a 3-year agreement increasing their collaboration in clinical supply optimization. With this new agreement, UCB will use the N-SIDE Suite for Clinical Trials solution and N-SIDE consulting services to optimize the supply management from protocol design to on-going clinical trials.
The UCB Clinical Supply Optimization team will work with the N-SIDE Suite for Clinical Trials, a SaaS solution, having Power user access. This specific access and the integration of the N-SIDE solution into UCB internal clinical supply management processes will empower them to optimize their clinical supply management from start to finish while proactively managing the risk.
The UCB Clinical Supply Optimization team members will be able to work seamlessly with N-SIDE consultants within the N-SIDE Suite for Clinical Trials to achieve efficient and optimal trial supply management. Knowing that some trials require urgent impact assessments related to manufacturing and clinical updates, this increased collaboration and integration augments the flexibility and reactivity to take appropriate supply chain decisions. Also, by leveraging real-time enrollment and inventory information in the N-SIDE Suite for Clinical Trials, UCB will be positioned to react quickly to unexpected changes and realign the clinical supply management accordingly. This will allow for further reduction in drug waste and cost savings while ensuring that there is no risk to patients receiving their medication on-time.
“With this implementation we seek to improve integration between UCB & N-SIDE solutions to leverage the respective specific capabilities and expertise to generate better demand forecasts. The Supply App, part of the N-SIDE Suite for Clinical Trials, offers improved collaboration support. Thus, this new application would be of substantial value for us by supporting the integration of UCB and N-SIDE teams in the simulation process flow.” Philippe Verlaine, Head of Clinical Supply Optimization, UCB.
“We are proud to grow our collaboration with UCB as they implement the N-SIDE Suite of Clinical Trials. With the N-SIDE Suite for Clinical Trials, we can provide a new, efficient way of working together to reduce waste and optimize supply decisions throughout the management of clinical trials.” Jacques Parlongue, CEO, N-SIDE.
Both headquartered in Belgium, N-SIDE and UCB have had a consulting agreement in place since 2012, with N-SIDE providing strategic consulting services to UCB for clinical supply optimization.
The N-SIDE Suite for Clinical Trials is a cutting edge, cloud-based software that enables clinical trial managers to future-proof their clinical trial supply chain management while minimizing costs, drug waste and risk. With interconnected applications, the N-SIDE Suite for Clinical Trials uses advanced analytics, including optimization and machine learning, to support strategic and operational decision-making as well as facilitate trial monitoring with real-time data and knowledge sharing.
Notes to editors
N-SIDE is an innovative software consulting company in advanced analytics designing optimization solutions for Life Sciences and Energy management.
From strategy down to operations, N-SIDE leverages the value of your data and business knowledge into decision-making power. Our cloud-based custom solutions use cutting-edge technologies such as machine learning and powerful algorithms to solve the most complex industry challenges and turn them into opportunities.
We empower organizations with agility and data-driven decisions to optimize processes and use resources wisely while efficiently managing risk and maximizing profits. We ensure our customers are ahead of the game!
N-SIDE optimizes decisions of some of the largest companies around the world, across a vast range of industries: Pharmaceuticals, Power Exchanges, TSO’s and DSO’s, etc.
For further information, contact:
Sylvia Haller, Life Sciences Marketing Manager
Juliette Craggs/Deborah Cockerill/Victoria Deaner
T: +44 (0)20 3405 7892
BiotechnologyClinical TrialsInformation TechnologyLife ScienceMedical TechnologyPharmaceuticalPress Release